Literature DB >> 18414868

A mandibular osteolytic lesion in a systemic lupus erythematosus patient on long-standing bisphosphonate therapy.

Charalampos E Papagoras, Vasilios G Botzoris, Paraskevi V Voulgari, Alexandros A Drosos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18414868     DOI： 10.1007/s00296-008-0580-1

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN： 0172-8172            Impact factor:   2.631


× No keyword cloud information.
  9 in total

1.  Bisphosphanates and oral cavity avascular bone necrosis.

Authors:  Cesar A Migliorati
Journal:  J Clin Oncol       Date:  2003-11-15       Impact factor: 44.544

2.  [Aseptic necrosis of the temporomandibular joint in systemic lupus erythematosus].

Authors:  V M Grinin; Iu M Maksimovskiĭ; V A Nasonova
Journal:  Stomatologiia (Mosk)       Date:  1999

3.  Bone necrosis of the jaws associated with bisphosphonate treatment: a report of twenty-nine cases.

Authors:  Elisabetta Merigo; Maddalena Manfredi; Marco Meleti; Rebecca Guidotti; Alessandro Ripasarti; Elisa Zanzucchi; Pietro D'Aleo; Domenico Corradi; Luigi Corcione; Enrico Sesenna; Silvano Ferrari; Tito Poli; Mauro Bonaninil; Paolo Vescovi
Journal:  Acta Biomed       Date:  2006-08

Review 4.  Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws.

Authors:  Sook-Bin Woo; John W Hellstein; John R Kalmar
Journal:  Ann Intern Med       Date:  2006-05-16       Impact factor: 25.391

5.  Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment.

Authors:  Robert E Marx; Joseph E Cillo; Juan J Ulloa
Journal:  J Oral Maxillofac Surg       Date:  2007-12       Impact factor: 1.895

Review 6.  Osteonecrosis of the mandible or maxilla associated with the use of new generation bisphosphonates.

Authors:  Matthew C Farrugia; Don-John Summerlin; Edward Krowiak; Tod Huntley; Stephen Freeman; Richard Borrowdale; Charles Tomich
Journal:  Laryngoscope       Date:  2006-01       Impact factor: 3.325

7.  Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research.

Authors:  Sundeep Khosla; David Burr; Jane Cauley; David W Dempster; Peter R Ebeling; Dieter Felsenberg; Robert F Gagel; Vincente Gilsanz; Theresa Guise; Sreenivas Koka; Laurie K McCauley; Joan McGowan; Marc D McKee; Suresh Mohla; David G Pendrys; Lawrence G Raisz; Salvatore L Ruggiero; David M Shafer; Lillian Shum; Stuart L Silverman; Catherine H Van Poznak; Nelson Watts; Sook-Bin Woo; Elizabeth Shane
Journal:  J Bone Miner Res       Date:  2007-10       Impact factor: 6.741

8.  Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases.

Authors:  Salvatore L Ruggiero; Bhoomi Mehrotra; Tracey J Rosenberg; Stephen L Engroff
Journal:  J Oral Maxillofac Surg       Date:  2004-05       Impact factor: 1.895

Review 9.  Bisphosphonate-associated osteonecrosis of the jaw: the rheumatologist's role.

Authors:  Franco Capsoni; Matteo Longhi; Roberto Weinstein
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.